Whats Going On With Reunion Neuroscience Stock Today
REUNDelisted Stock | USD 1.12 0.01 0.90% |
About 51% of Reunion Neuroscience's investor base is interested to short. The analysis of current outlook of investing in Reunion Neuroscience suggests that many traders are impartial regarding Reunion Neuroscience's prospects. Reunion Neuroscience's investing sentiment overview a quick insight into current market opportunities from investing in Reunion Neuroscience. Many technical investors use Reunion Neuroscience stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Reunion |
Reunion Neuroscience Inc. shares are trading lower on Friday after inking a take-private deal with MPM BioImpact, where MPM would acquire Reunion for 13.1 million under the Canadian Business Corporations Act. Per the terms of the agreement, Reunion will receive 1.12 in cash for each share held in the company. In the last weeks of December 2022, the company struggled to remain NASDAQ listed as the bid price of the company was below 1.00. Based on the Bank of Canadas daily excha
Read at finance.yahoo.com
Reunion Neuroscience Fundamental Analysis
We analyze Reunion Neuroscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reunion Neuroscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reunion Neuroscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Reunion Neuroscience is currently under evaluation in target price category among its peers.
Reunion Neuroscience Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reunion Neuroscience stock to make a market-neutral strategy. Peer analysis of Reunion Neuroscience could also be used in its relative valuation, which is a method of valuing Reunion Neuroscience by comparing valuation metrics with similar companies.
Peers
Reunion Neuroscience Related Equities
CING | Cingulate | 11.60 | ||||
SNTI | Senti Biosciences | 0.77 | ||||
NUVL | Nuvalent | 2.10 | ||||
ONTTF | Oxford Nanopore | 2.96 | ||||
PHGUF | Pharming Group | 3.06 | ||||
ACUT | Accustem Sciences | 4.26 | ||||
OKYO | OKYO Pharma | 12.40 | ||||
SABSW | SAB Biotherapeutics | 15.38 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Reunion Stock
If you are still planning to invest in Reunion Neuroscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reunion Neuroscience's history and understand the potential risks before investing.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |